No internet connection — showing the saved version of the page.

Quest Diagnostics…

USUSD
← to the screener
US:DGXLSE:0KSX

Quest Diagnostics Incorporated (LSE:0KSX) — Medical Specialities. Number of exchanges where the company shares trade: 2. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
questdiagnostics.com
Investor relations
ir.questdiagnostics.com/overview/default.aspx
Sector
Health Care · Medical Specialities
Headquarters
Madison, United States
CEO
Steve Rusckowski
Employees
46 000
Founded
1967
Listed since
29.01.2018 (LSE:0KSX)
Shares outstanding
110.37 M as of 2026-07-15
Free float
109.81 M
Market cap
25.21 B USD
Insiders
0.43%
Institutions
98.9%
Industry (SIC)
Services-Medical Laboratories
LEI
8MCWUBXQ0WE04KMXBX50
P/E
15.4
Payout ratio
34.2%
FCF
1.35 B USD
Payout / FCF
27%
Debt
5.64 B USD
3.7 y of FCF
Dividend streak
22 y
Earnings, FCF and dividends paid — for the 12 months to 30.06.2026 (the company's latest report).
NAV
68.10 USD · P/NAV 3.40
Balance sheet date30.06.2026
Assets16.9 B USD
− Liabilities9.12 B USD
= Total equity7.82 B USD
− Non-controlling interests303 M USD
= NAV (equity of the company's shareholders)7.52 B USD
− Goodwill9.11 B USD
− Intangible assets1.67 B USD
= Tangible NAV−3.27 B USD
Shares110 373 360
NAV per share68.10 USD
Tangible NAV per share−29.61 USD
Share price (0KSX)231.43 USD
P/NAV3.40
NAV history
Balance sheet dateNAVNAV per share
30.06.20267.52 B USD68.10 USD
31.03.20267.37 B USD66.54 USD
31.12.20257.17 B USD65.26 USD
30.09.20257.26 B USD65.24 USD
30.06.20257.23 B USD64.64 USD
31.03.20256.93 B USD62.07 USD
31.12.20246.78 B USD61.08 USD
30.09.20246.81 B USD61.00 USD
Description

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
US USA StocksDGX primaryUSD235 -1.74%common stock
LSE London Stock Exchange0KSX IOBUSD231.43 +0.00%common stock

Price for 3 months

up day down day dividend ex-date payment dateHover / tap a day — open, close, high and low prices

Dividends

Per year, US:DGX: 3.38 USD (4 paym.)

Quest Diagnostics Incorporated (DGX) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 3.38 USD per share (payments: 4). That is about 1.44% of the current share price. Based on payment history, the next ex-dividend date is expected around 05.01.2027. Uninterrupted dividend history: 22 years.

Ex-datePaymentAmount%TypeTicker
2026-10-062026-10-210.8600 USD0.4/1.5 %quarterlyUS:DGX
2026-07-082026-07-220.8600 USD0.4/1.6 %quarterlyUS:DGX
2026-04-062026-04-200.8600 USD0.4/1.6 %quarterlyUS:DGX
2026-01-132026-01-280.8000 USD0.5/1.8 %quarterlyUS:DGX
2025-10-032025-10-200.8000 USD0.4/1.7 %quarterlyUS:DGX
2025-07-072025-07-210.8000 USD0.5/1.8 %quarterlyUS:DGX
2025-04-072025-04-210.8000 USD0.5/1.9 %quarterlyUS:DGX
2025-01-142025-01-290.7500 USD0.5/1.9 %quarterlyUS:DGX
2024-10-042024-10-210.7500 USD0.3/1.3 %quarterlyUS:DGX
2024-07-082024-07-220.7500 USD0.3/1.2 %quarterlyUS:DGX
2024-04-052024-04-220.7500 USD0.3/≈1.3 %quarterlyUS:DGX
2024-01-162024-01-310.7100 USD0.3/≈1.2 %quarterlyUS:DGX
2023-10-052023-10-230.7100 USD0.3/≈1.2 %quarterlyUS:DGX

News this week

Press releases from the company's investor website, updated daily. Links lead to the company's website. Headlines are in the original language, as on the company website.

Top holders

HolderStakeSharesReport date
Blackrock Inc.8.4%9.28 M2026-06-30
Vanguard Capital Managem…6.55%7.23 M2026-06-30
Vanguard Portfolio Manag…5.55%6.13 M2026-06-30
State Street Corporation5%5.52 M2026-06-30
Price (T.Rowe) Associate…4.93%5.44 M2026-06-30
Boston Partners4.3%4.74 M2026-06-30
JPMORGAN CHASE & CO3.19%3.52 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%3.51 M2026-06-30
Geode Capital Management…2.84%3.14 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.6%2.87 M2026-06-30
Morgan Stanley2.23%2.46 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.17%2.4 M2026-06-30
Edgepoint Investment Gro…2.04%2.25 M2026-06-30
iShares Trust-iShares Co…1.33%1.47 M2026-08-31
Fidelity Concord Street…1.3%1.43 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%1.36 M2026-08-31
John Hancock Funds III-D…1.09%1.2 M2026-07-31
JPMorgan Trust II-JPMorg…1.04%1.15 M2026-06-30
T. Rowe Price Dividend G…1%1.11 M2026-06-30
John Hancock Funds III-D…0.96%1.06 M2026-07-31
DAVIS J E CAUSEY (Chief…≈0.13%142 4232026-03-04
DAVIS JAMES E (Chief Exe…≈0.11%122 4232026-09-01
DOHERTY CATHERINE T (Off…≈0.06%71 6242026-03-05
PREVOZNIK MICHAEL E (Gen…≈0.04%42 3372026-08-28
DEPPE MICHAEL J (Officer…≈0.03%35 1962026-03-04
SAMAD SAMER ABDUL (Chief…≈0.03%33 4782026-07-22
RING TIMOTHY M (Director…≈0.03%31 1402026-05-20
PFEIFFER GARY M (Directo…≈0.03%31 0052026-05-20
MAIN TIMOTHY L (Director…≈0.02%27 4602026-07-22
GREGG VICKY B (Director)≈0.02%18 3862026-07-22